Prokop Vodička (Prokop Vodicka)

Years Active: 2022-2023
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Martin Špaček, Lukáš Smolej, Martin Šimkovič, Lucie Nekvindová, Zlatuše Křístková, Yvona Brychtová, Anna Panovská, Stanislava Mašlejová, Lucie Bezděková, Dominika Écsiová, Pavel Vodárek, Jana Zuchnická, Jana Mihályová, Renata Urbanová, Peter Turcsanyi, Daniel Lysák, Jan Novák, Martin Brejcha, Tereza Líkařová, Prokop Vodička, Jana Baranová, Marek Trněný, Michael Doubek, null null
Idelalisib plus rituximab versus ibrutinib in the treatment of relapsed/refractory chronic lymphocytic leukaemia: A real-world analysis from the Chronic Lymphocytic Leukemia Patients Registry (CLLEAR). British journal of haematology (2023)
Prokop Vodička, Pavel Klener, Marek Trneny
Diffuse Large B-Cell Lymphoma (DLBCL): Early Patient Management and Emerging Treatment Options. OncoTargets and therapy 15 (2022)
Prokop Vodička, Pavel Klener, Marek Trneny
Diffuse Large B-Cell Lymphoma (DLBCL): Early Patient Management and Emerging Treatment Options. OncoTargets and therapy 15 (2022)

Prokop Vodička.css-eqlu8i{font-size:small;padding-left:4px;} (Prokop Vodicka)